Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Industry update Australia to spend $14.5M on psychedelic drug trials Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD Jared GnamMarch 17, 2021